HK1254918A1 - Etar antibody, pharmaceutical composition thereof and use thereof - Google Patents

Etar antibody, pharmaceutical composition thereof and use thereof

Info

Publication number
HK1254918A1
HK1254918A1 HK18114017.0A HK18114017A HK1254918A1 HK 1254918 A1 HK1254918 A1 HK 1254918A1 HK 18114017 A HK18114017 A HK 18114017A HK 1254918 A1 HK1254918 A1 HK 1254918A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
etar antibody
etar
antibody
pharmaceutical
Prior art date
Application number
HK18114017.0A
Other languages
Chinese (zh)
Inventor
張成
范克索
郭勇
景書謙
Original Assignee
鴻運華寧(杭州)生物醫藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 鴻運華寧(杭州)生物醫藥有限公司 filed Critical 鴻運華寧(杭州)生物醫藥有限公司
Priority to HK18114017.0A priority Critical patent/HK1254918A1/en
Publication of HK1254918A1 publication Critical patent/HK1254918A1/en

Links

HK18114017.0A 2018-11-02 2018-11-02 Etar antibody, pharmaceutical composition thereof and use thereof HK1254918A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18114017.0A HK1254918A1 (en) 2018-11-02 2018-11-02 Etar antibody, pharmaceutical composition thereof and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18114017.0A HK1254918A1 (en) 2018-11-02 2018-11-02 Etar antibody, pharmaceutical composition thereof and use thereof

Publications (1)

Publication Number Publication Date
HK1254918A1 true HK1254918A1 (en) 2019-08-02

Family

ID=71576166

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114017.0A HK1254918A1 (en) 2018-11-02 2018-11-02 Etar antibody, pharmaceutical composition thereof and use thereof

Country Status (1)

Country Link
HK (1) HK1254918A1 (en)

Similar Documents

Publication Publication Date Title
ZA202101894B (en) Anti-pd-1 and anti-vegfa bifunctional antibody, pharmaceutical composition thereof and use thereof
IL279015A (en) Anti-interleukin-17a antibody, pharmaceutical composition thereof and use thereof
HK1247214B (en) Pdl-1 antibody, pharmaceutical composition thereof, and uses thereof
EP3505535A4 (en) Anti-pd1 monoclonal antibody, pharmaceutical composition thereof and use thereof
ZA201806576B (en) Antibodies, pharmaceutical compositions and methods
SG11202105850YA (en) Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof
SG11202003782XA (en) Triple-chain antibody, method for preparation and use thereof
EP3597735A4 (en) Ctla4 antibody, pharmaceutical composition and use thereof
ZA202206885B (en) Anti-pd-1-anti-vegfa bispecific antibody, pharmaceutical composition and use thereof
EP3491026A4 (en) Human antibodies, pharmaceutical compositions and methods
IL275798A (en) Methods for antibody drug conjugation, purification, and formulation
EP3626266A4 (en) Pd-l1 antibody pharmaceutical composition and use thereof
IL290256A (en) Anti-pd-1 antibody and pharmaceutical use thereof
IL273339A (en) Griseofulvin compound and pharmaceutical use thereof
ZA202104518B (en) Cd3 antibody and pharmaceutical use thereof
EP3714901A4 (en) Lag-3 antibody pharmaceutical composition and use thereof
EP4032904A4 (en) Anti-alpha-hemolysin antibody and use thereof
SG11202101435XA (en) ANTIBODY AGAINST IL-1ß, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3856242A4 (en) Anti-siglec antibody, pharmaceutical composition comprising the same, and uses thereof
IL276323A (en) 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
IL274008A (en) Anti-msln antibody and pharmaceutical composition comprising same for cancer treatment
SG11202011170YA (en) Antibodies against lif and dosage forms thereof
EP3476864A4 (en) Etar antibody, pharmaceutical composition and use thereof
GB2590189B (en) Lycorine derivative, and pharmaceutical composition and use thereof
EP3623384A4 (en) Anti-cldn-5 antibody, and drug containing said antibody